Photocrosslinking probes to discover glycan-dependent interactions
光交联探针发现聚糖依赖性相互作用
基本信息
- 批准号:9166533
- 负责人:
- 金额:$ 31.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-25 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAlzheimer&aposs DiseaseBindingBiochemistryBiologicalBiological AssayBiological ModelsBiological ProcessBiologyCardiovascular DiseasesCell LineCellsChemicalsCommunitiesComplexCore FacilityCovalent InteractionCytoplasmic ProteinDevelopmentDiabetes MellitusDiazomethaneDiseaseEnsureEnvironmentGlycopeptidesGoalsHousingImmunoblottingIn VitroInterest GroupLaboratoriesLettersLifeLinkMalignant NeoplasmsMass Spectrum AnalysisMediatingMedical centerMethodsModificationNeurodegenerative DisordersNon-Insulin-Dependent Diabetes MellitusNuclear Pore Complex ProteinsNuclear ProteinsOutcomePeptide SynthesisPeptidesPlant ProteinsPlasmidsPolysaccharidesPost-Translational Protein ProcessingProceduresProteinsProteomicsProtocols documentationReagentReportingResearchRoleStimulusStressSystemVascular PlantWorkWorkplacebasebiomedical scientistcandidate identificationcellular engineeringcrosslinkfunctional groupimprovedinnovationinsightmethod developmentnanoparticlenovelprotein functionresponsetoolultraviolet irradiation
项目摘要
The goal of this project is to develop accessible and effective methods to discover the interaction partners of
proteins that are modified with O-linked beta-N-acetylglucosamine (O-GlcNAc). O-GlcNAc is a common post-
translational modification of intracellular proteins in metazoa and higher plants. Hundreds of O-GlcNAc-
modified nuclear and cytoplasmic proteins have been identified. Although O-GlcNAc is both abundant and
essential, little is known about how it affects the function of modified proteins. The central hypothesis of the
proposed work is that O-GlcNAc-modified proteins are surrounded by a different set of molecules than the
unmodified proteins. Obtaining information about the interaction partners of O-GlcNAc-modified proteins
will provide new insight into O-GlcNAc function. To identify O-GlcNAc interaction partners, we will rely on a
photocrosslinking approach to convert low-affinity glycan-dependent interactions to high-affinity covalent
complexes that can be purified and characterized by mass spectrometry. Two complementary approaches will
be pursued: an in-lysate photocrosslinking approach (Aim 1) and an in-cell photocrosslinking approach (Aim
2). In the first aim, a panel of photocrosslinking glycopeptide probes will be prepared. These molecules will be
crosslinked to proteins in lysate. The crosslinked complexes will be isolated and the interaction partners will
be identified by mass spectrometry. The outcome of this aim will be an in-lysate photocrosslinking method
that has the following features: (a) probe molecules produced by routine, simple methods, (b) probe molecules
crosslinked efficiently and specifically to interacting proteins, (c) LC-MS/MS delivering a high yield of tryptic
peptides from a specific subset of proteins, and (d) candidate interacting proteins confirmed by in vitro and
cell-based assays. In the second aim, a photocrosslinking functional group will be incorporated onto O-GlcNAc
residues in living cells. Subsequent UV irradiation will result in covalent crosslinking of O-GlcNAc-associated
interactions in their native cellular context. As in Aim 1, the crosslinked complexes will be isolated and the
interaction partners will be identified by mass spectrometry. The basic features of this in-cell
photocrosslinking method have already been reported; the aim of this proposal is to make the method more
effective and powerful by (a) engineering cells to produce more O-GlcNDAz, (b) purifying crosslinked material
more efficiently and stringently, and (c) improving confidence in candidate hit identification. The reagents and
methods developed will be shared with other research groups to enable study of a wide variety of O-GlcNAc-
modified proteins with diverse biological functions. The proposed work places a high priority on approaches
that are simple to implement and make use of “off-the-shelf” reagents and procedures. Making these methods
available to the broad biomedical community is significant because dysregulation of O-GlcNAc is associated
with multiple disease states including type II diabetes, cardiovascular disease, Alzheimer's disease, and several
cancers.
该项目的目的是开发可访问有效的方法,以发现
用O连锁β-N-乙酰葡萄糖胺(O-GLCNAC)修饰的蛋白质。 O-GLCNAC是一个常见的后
转化的细胞内蛋白质和高等植物中的细胞内蛋白质。数百个O-glcnac-
已经鉴定出修饰的核和细胞质蛋白。虽然O-GlcNAC既丰富又
对于它如何影响修饰蛋白的功能,重要的是,知之甚少。中心假设
拟议的工作是O-GlCNAC修饰的蛋白质与不同的分子围绕着
未改性的蛋白质。获取有关O-GLCNAC修饰蛋白的相互作用伙伴的信息
将提供有关O-GLCNAC功能的新见解。要识别O-GLCNAC互动伙伴,我们将依靠
将低亲和力聚糖依赖性相互作用转换为高亲和力共价的光链接方法
可以通过质谱法纯化和表征的复合物。两种完整的方法将
被追捕:一种赖以生殖的光链接方法(AIM 1)和一个内部的光链接方法(AIM
2)。在第一个目标中,将准备一系列光叠型糖肽探针。这些分子将是
在裂解物中交联至蛋白质。交联的复合物将被隔离,相互作用伙伴将
通过质谱法识别。这个目标的结果将是一种赖以生态的光链接方法
具有以下特征:(a)通过常规,简单方法产生的探针分子,(b)探针分子
有效,专门针对相互作用的蛋白质交联,(c)LC-MS/MS提供高胰蛋白酶的产量
来自特定蛋白质的特定子集的肽,以及(d)通过体外和
基于细胞的测定。在第二个目的中,将在O-GLCNAC上纳入光链接功能组
活细胞中的残留物。随后的紫外线照射将导致O-GLCNAC相关的共价交联
在其天然细胞环境中的相互作用。与AIM 1一样,交联的复合物将被隔离,并
相互作用伙伴将通过质谱识别。此室内的基本功能
已经报道了Photocropslinking方法;该提议的目的是使方法更加
(a)工程单元生成更多的O-Glcndaz,(b)净化交联材料的有效和强大
更有效,更严格,以及(c)提高对候选命中识别的信心。试剂和
开发的方法将与其他研究小组共享,以研究各种O-GlcNAC-
具有潜水生物学功能的修饰蛋白质。拟议的工作将高度重视
易于实施并利用“现成”试剂和程序。制作这些方法
可用于广泛的生物医学界非常重要,因为O-GLCNAC的失调与
具有多种疾病状态,包括II型糖尿病,心血管疾病,阿尔茨海默氏病和几种
癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jennifer J Kohler其他文献
Transcriptional Control of Gene Expression By O-Glcnacylation during Erythropoiesis
- DOI:
10.1182/blood-2024-201756 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Kenneth R Peterson;Matthew P Parker;Aspin Denson;Will Brautman;Nick Lowe;Halyna Fedosyuk;Lesya V Novikova;Jeffrey A Thompson;Jennifer J Kohler;Chad Slawson - 通讯作者:
Chad Slawson
Jennifer J Kohler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jennifer J Kohler', 18)}}的其他基金
Function and regulation of epithelial glycosylation
上皮糖基化的功能和调节
- 批准号:
10621189 - 财政年份:2022
- 资助金额:
$ 31.41万 - 项目类别:
DISSECTING AND TARGETING THE ROLE OF GALNT14 IN HIGH-RISK OSTEOSARCOMA
剖析和瞄准 GALNT14 在高风险骨肉瘤中的作用
- 批准号:
10761850 - 财政年份:2022
- 资助金额:
$ 31.41万 - 项目类别:
DISSECTING AND TARGETING THE ROLE OF GALNT14 IN HIGH-RISK OSTEOSARCOMA
剖析和瞄准 GALNT14 在高风险骨肉瘤中的作用
- 批准号:
10363579 - 财政年份:2022
- 资助金额:
$ 31.41万 - 项目类别:
Function and regulation of epithelial glycosylation
上皮糖基化的功能和调节
- 批准号:
10414154 - 财政年份:2022
- 资助金额:
$ 31.41万 - 项目类别:
Discovery of small molecule inhibitors of GalNAc-type O-linked glycosylation
GalNAc 型 O-连接糖基化小分子抑制剂的发现
- 批准号:
9763582 - 财政年份:2018
- 资助金额:
$ 31.41万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 31.41万 - 项目类别:
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 31.41万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 31.41万 - 项目类别:
Dopaminergic mechanisms of resilience to Alzheimer's disease neuropathology
阿尔茨海默病神经病理学恢复的多巴胺能机制
- 批准号:
10809199 - 财政年份:2023
- 资助金额:
$ 31.41万 - 项目类别:
Towards the discovery of Nurr1-RXR modulators
致力于发现 Nurr1-RXR 调制器
- 批准号:
10750409 - 财政年份:2023
- 资助金额:
$ 31.41万 - 项目类别: